Singapore
CBC Group Appoints Billy Cho as Senior Managing Director, Private Equity and Co-Head, Joint Value Creation
CBC Group (“CBC”), Asia’s largest healthcare-dedicated investment firm headquartered in Singapore, today announced the appointment of Billy Cho as Senior Managing Director, Private Equity and Co-Head, Joint Value Creation.
Singapore’s Thomson Medical buys Vietnam’s FV Hospital
SGX Mainboard-listed healthcare group Thomson Medical Group (TMG) has agreed to acquire Vietnam's FV Hospital for up to $381.4 million,.
Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023
Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities is a finalist in the Asia Pacific Cell & Gene Therapy Awards 2023.
Eblasakimab Monthly Dosing Shows Potential for Best-In-Class Therapy in Positive Phase 2b Study in Atopic Dermatitis
ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced positive topline data from its Phase 2b dose-ranging study of eblasakimab in adult patients with moderate-to-severe atopic dermatitis (AD), the TREK-AD (TRials with EblasaKimab in Atopic Dermatitis) study.
Genesis MedTech Receives Approval for Launch in China for ArtiSential™
Genesis MedTech, a leading medical device company, today announced that its ArtiSential™, a revolutionary series of articulating laparoscopic instruments, has successfully obtained approval from the China's National Medical Products Administration (NMPA) for market release.
Temasek-backed Tessa Therapeutics to cease operations after failure to raise funding
TESSA Therapeutics, one of the top-funded biotech startups in Singapore, will soon enter liquidation after failing to find investors to continue funding the development of its cancer treatment cell therapies.
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma
SINGAPORE, June 27, 2023 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce that a new therapy to treat the most common type of non-Hodgkin lymphoma in adults – diffuse large B-cell lymphoma – is now approved for use in Australia.
Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced the official opening of its latest Good Manufacturing Practice (GMP) facility in Singapore.
HistoIndex Presents Advancements in AI-powered Stain-free Tissue Imaging for NASH Clinical Trials at EASL Congress 2023
SINGAPORE, June 21, 2023 /PRNewswire/ -- HistoIndex today announced that the Company, alongside its collaborators, will present new data on its novel stain-free tissue imaging technology using clinically validated artificial intelligence (AI) algorithms at the EASL Congress, taking place June 21-24, 2023.
Zeta Surgical Announces Successful Treatment of First Patient in Neurosurgical Navigation Clinical Trial at Singapore’s National Neuroscience Institute
SINGAPORE, June 22, 2023 /PRNewswire/ -- Zeta Surgical, a surgical robotics and mixed reality company, has successfully treated its first patient using the Zeta Cranial Navigation System as part of their first-in-human trial at Singapore's National Neuroscience Institute (NNI).
